AprilBio Co Ltd
KOSDAQ:397030
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
11 070
25 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
AprilBio Co Ltd
Operating Income
AprilBio Co Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
AprilBio Co Ltd
KOSDAQ:397030
|
Operating Income
-₩13.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Operating Income
₩369.6B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Operating Income
-₩12B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Hugel Inc
KOSDAQ:145020
|
Operating Income
₩156.5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Operating Income
₩102.2B
|
CAGR 3-Years
31%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Operating Income
-₩5.7B
|
CAGR 3-Years
39%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
AprilBio Co Ltd
Glance View
AprilBio Co Ltd is a Korea-based company primarily engaged in the biological drug development business. The Company is primarily engaged in the bio-innovative new drug research and development (R&D) business such as antibody therapeutics and long-acting recombinant protein pharmaceuticals.
See Also
What is AprilBio Co Ltd's Operating Income?
Operating Income
-13.4B
KRW
Based on the financial report for Dec 31, 2023, AprilBio Co Ltd's Operating Income amounts to -13.4B KRW.
What is AprilBio Co Ltd's Operating Income growth rate?
Operating Income CAGR 3Y
-13%
Over the last year, the Operating Income growth was -17%. The average annual Operating Income growth rates for AprilBio Co Ltd have been -13% over the past three years .
You don't have any saved screeners yet
